Economics of Obesity and Metabolic Health Summit 2026

Obesity is one of the fastest-growing and most costly public-health crises of our time

The condition already places immense strain on overburdened health systems. And the global cost of obesity and metabolic disorders, including direct healthcare costs and the impact of lost productivity and premature death, is projected to exceed $4trn annually by 2035.

The last decade has seen transformations in obesity and metabolic health management including GLP-1 medications, surgical breakthroughs and innovative weight-management clinics. Digital platforms and artificial intelligence are also reshaping care delivery. How can governments and health leaders afford to prevent and manage obesity at scale? They can’t afford not to. Spending to reduce obesity is an investment in a healthier population and workforce. Reducing obesity rates will also benefit other areas of health including diabetes, cancer and heart disease.

The Economics of Obesity and Metabolic Health Summit will bring together policymakers, public-health experts, clinicians, advocacy groups, people living with obesity and metabolic disorders, scientists, pharmaceutical executives, weight-management and lifestyle support providers, technology developers and investors to discuss the economics of obesity and how to improve global health.